Editorial
IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?
Nefropatía IgA: ¿qué pacientes están en riesgo de progresar a enfermedad renal terminal y cómo deberían ser tratados?
Manuel Pragaa,b,
, Fernando Caravacaa, Claudia Yustea, Teresa Caveroa, Eduardo Hernándeza, Enrique Moralesa, Eva Méridaa, Juan Antonio Morenoc, Angel Sevillanoa, Eduardo Gutiérreza
Corresponding author
a Servicio de Nefrología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria, Hospital 12 de Octubre (imas12), Madrid, Spain
b Departamento de Medicina, Universidad Complutense, Madrid, Spain
c Renal, Vascular and Diabetes Research Laboratory, Fundación Instituto de Investigaciones Sanitarias-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain
Read
27693
Timeswas read the article
4172
Total PDF
23521
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 212 | 42 | 254 |
| 2025 5 | 376 | 66 | 442 |
| 2025 4 | 309 | 44 | 353 |
| 2025 3 | 309 | 67 | 376 |
| 2025 2 | 262 | 49 | 311 |
| 2025 1 | 206 | 55 | 261 |
| 2024 12 | 141 | 28 | 169 |
| 2024 11 | 144 | 62 | 206 |
| 2024 10 | 229 | 58 | 287 |
| 2024 9 | 143 | 40 | 183 |
| 2024 8 | 206 | 64 | 270 |
| 2024 7 | 239 | 37 | 276 |
| 2024 6 | 310 | 53 | 363 |
| 2024 5 | 354 | 49 | 403 |
| 2024 4 | 321 | 45 | 366 |
| 2024 3 | 375 | 32 | 407 |
| 2024 2 | 359 | 55 | 414 |
| 2024 1 | 348 | 37 | 385 |
| 2023 12 | 229 | 39 | 268 |
| 2023 11 | 313 | 35 | 348 |
| 2023 10 | 428 | 35 | 463 |
| 2023 9 | 258 | 40 | 298 |
| 2023 8 | 311 | 27 | 338 |
| 2023 7 | 290 | 34 | 324 |
| 2023 6 | 220 | 34 | 254 |
| 2023 5 | 228 | 45 | 273 |
| 2023 4 | 238 | 28 | 266 |
| 2023 3 | 220 | 33 | 253 |
| 2023 2 | 154 | 33 | 187 |
| 2023 1 | 166 | 39 | 205 |
| 2022 12 | 213 | 52 | 265 |
| 2022 11 | 188 | 46 | 234 |
| 2022 10 | 169 | 51 | 220 |
| 2022 9 | 138 | 50 | 188 |
| 2022 8 | 149 | 50 | 199 |
| 2022 7 | 245 | 57 | 302 |
| 2022 6 | 226 | 48 | 274 |
| 2022 5 | 189 | 43 | 232 |
| 2022 4 | 207 | 59 | 266 |
| 2022 3 | 192 | 53 | 245 |
| 2022 2 | 200 | 80 | 280 |
| 2022 1 | 170 | 46 | 216 |
| 2021 12 | 146 | 58 | 204 |
| 2021 11 | 190 | 66 | 256 |
| 2021 10 | 240 | 56 | 296 |
| 2021 9 | 200 | 54 | 254 |
| 2021 8 | 198 | 57 | 255 |
| 2021 7 | 190 | 39 | 229 |
| 2021 6 | 179 | 34 | 213 |
| 2021 5 | 193 | 78 | 271 |
| 2021 4 | 847 | 164 | 1011 |
| 2021 3 | 463 | 64 | 527 |
| 2021 2 | 328 | 63 | 391 |
| 2021 1 | 271 | 44 | 315 |
| 2020 12 | 268 | 52 | 320 |
| 2020 11 | 243 | 28 | 271 |
| 2020 10 | 239 | 29 | 268 |
| 2020 9 | 261 | 34 | 295 |
| 2020 8 | 260 | 44 | 304 |
| 2020 7 | 226 | 38 | 264 |
| 2020 6 | 227 | 43 | 270 |
| 2020 5 | 284 | 61 | 345 |
| 2020 4 | 257 | 57 | 314 |
| 2020 3 | 346 | 52 | 398 |
| 2020 2 | 411 | 55 | 466 |
| 2020 1 | 590 | 105 | 695 |
| 2019 12 | 568 | 52 | 620 |
| 2019 11 | 662 | 64 | 726 |
| 2019 10 | 752 | 68 | 820 |
| 2019 9 | 731 | 84 | 815 |
| 2019 8 | 564 | 70 | 634 |
| 2019 7 | 515 | 70 | 585 |
| 2019 6 | 469 | 70 | 539 |
| 2019 5 | 390 | 85 | 475 |
| 2019 4 | 394 | 77 | 471 |
| 2019 3 | 199 | 56 | 255 |
| 2019 2 | 129 | 21 | 150 |
| 2019 1 | 141 | 33 | 174 |
| 2018 12 | 118 | 35 | 153 |
| 2018 11 | 260 | 19 | 279 |
| 2018 10 | 179 | 12 | 191 |
| 2018 9 | 81 | 13 | 94 |
| 2018 8 | 58 | 10 | 68 |
| 2018 7 | 53 | 16 | 69 |
| 2018 6 | 17 | 2 | 19 |
Show all
